How to Respond to "Why Not Just Diet and Exercise?"

    By Trimi Medical Team8 min read

    Every GLP-1 patient hears it eventually: "Why don't you just eat less and move more?" It comes from friends, family, coworkers, and even strangers. While often well-intentioned, this question reflects a fundamental misunderstanding of obesity as a medical condition. Here are science-backed responses for every situation.

    The Science You Need to Know

    Before crafting your response, understand why "just diet and exercise" fails for most people with obesity:

    • 95% failure rate: Research shows that 95% of people who lose weight through diet alone regain it within 5 years
    • Hormonal resistance: When you lose weight, ghrelin (hunger hormone) increases by 20-30% and leptin (satiety hormone) decreases, creating biological pressure to regain
    • Metabolic adaptation: Your body reduces metabolic rate beyond what weight loss alone would predict, making maintenance increasingly difficult
    • Neurological factors: Obesity alters brain reward circuits, creating food cravings that are neurologically similar to addiction
    • Genetic component: 40-70% of BMI variation is genetically determined

    Scripts for Different Situations

    The Quick, Firm Response

    "I am treating a medical condition with medicine. Same as anyone with high blood pressure or diabetes."

    The Educational Response

    "Diet and exercise have a 95% long-term failure rate for obesity, not because people lack willpower but because the body actively fights weight loss through hormonal changes. GLP-1 medication addresses the biological mechanisms that make weight regain almost inevitable without treatment."

    The Analogy Response

    "Would you tell someone with depression to just think happy thoughts? Or someone with diabetes to just stop eating sugar? Obesity has biological drivers that medical treatment addresses. Diet and exercise are still part of my plan, but the medication helps my body actually respond to those efforts."

    The Boundary-Setting Response

    "My medical decisions are between me and my doctor. I appreciate your concern, but I am not looking for opinions on my treatment plan."

    The Redirect

    "I actually still diet and exercise. The medication makes my body actually respond to those efforts instead of fighting against them. It is not an alternative to healthy habits; it is what makes them effective."

    Key Points to Remember

    • You do not owe anyone an explanation about your medical treatment
    • Obesity is recognized as a chronic disease by the AMA, WHO, and every major medical organization
    • GLP-1 medications work WITH diet and exercise, not instead of them
    • Treating a disease with medication is never "cheating"
    • The person asking usually has never struggled with their weight and does not understand the biology

    Treat Your Health with Trimi

    No judgment. Just evidence-based care. Compounded semaglutide is $99/month and compounded tirzepatide is $125/month. Visit our treatment page to start.

    Frequently Asked Questions

    Do I have to tell people I am on GLP-1?

    Absolutely not. Your medical treatment is private. You can simply say "I changed my diet" or "I am working with a doctor on my health" and leave it at that.

    What if my doctor is the one saying "just diet and exercise"?

    Find a new doctor or seek a second opinion. A physician who dismisses medically treated obesity with "just diet and exercise" is not practicing evidence-based medicine. Obesity medicine specialists and telehealth providers like Trimi understand the science.

    How do I handle online judgment about GLP-1 medications?

    Social media commentary about GLP-1 is often uninformed. You do not need to engage with every opinion. If a comment is from someone you care about, share educational resources. Otherwise, protect your mental health by not engaging.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading